[Evaluation of the criteria used for the interruption of treatment in bacterial meningitis (persistent pleocytosis and hyperproteinorrhachia) (author's transl)].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002555:Cerebrospinal Fluid / Q000166:cytology*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D008583:Meningitis, Haemophilus / Q000134:cerebrospinal fluid; D008585:Meningitis, Meningococcal / Q000134:cerebrospinal fluid; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid
D000900:Anti-Bacterial Agents; D002556:Cerebrospinal Fluid Proteins
Evaluation des critères de l'interruption du traitement dans la méningite microbienne (pléiocytose et hyperprotéinorachie persistantes).